Roche (SWX:ROG) Stock Margin Expansion To 19.6% Tests Bullish Earnings NarrativesSimplywall·1 day ago, 04:17 PMRHHBY+1.45%
Tech and AI Integration Spark Major Reshuffles Across Unlikely SectorsGlobal Report·2 days ago, 04:13 AMNMR+0.41%WGS-6.75%
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD) | RHHBY Stock NewsStockTitan·2 days ago, 09:15 PMRHHBY+1.45%
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc | RHHBY Stock NewsStockTitan·Jul 22 at 04:00 PMRHHBY+1.45%
RO: 6% CER sales growth and robust pipeline offset currency headwinds in H1 2026Quartr·Jul 23 at 12:18 AMRHHBY+1.45%
Roche H1 FY26 IFRS operating profit drops 6% to CHF 9.7 billion; sales fall 2% to CHF 30.4 billionPUBT·Jul 23 at 12:13 AMRHHBY+1.45%
RO: Sales up 6% at CER, core profit up 10% at CER, but net income down 6% in CHF due to impairmentsQuartr·Jul 23 at 12:12 AMRHHBY+1.45%
